wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q28069829-2BE46FD5-EC8F-4031-AD46-1097891C35AF
Q28069829-2BE46FD5-EC8F-4031-AD46-1097891C35AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28069829-2BE46FD5-EC8F-4031-AD46-1097891C35AF
New Antiretroviral Treatment for HIV
P2860
Q28069829-2BE46FD5-EC8F-4031-AD46-1097891C35AF
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28069829-2BE46FD5-EC8F-4031-AD46-1097891C35AF
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
a5867b5d6b01c1d8267e38918cd7f44fc7dc2b0a
P2860
Efficacy and safety of efavirenz 400 mg daily versus 600 mg daily: 96-week data from the randomised, double-blind, placebo-controlled, non-inferiority ENCORE1 study.